161 related articles for article (PubMed ID: 31605013)
1. PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1.
Ji J; Ding K; Luo T; Xu R; Zhang X; Huang B; Chen A; Zhang D; Miletic H; Bjerkvig R; Thorsen F; Wang J; Li X
Oncogene; 2020 Jan; 39(5):1125-1139. PubMed ID: 31605013
[TBL] [Abstract][Full Text] [Related]
2. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
Yeung B; Ho KC; Yang X
PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
[TBL] [Abstract][Full Text] [Related]
3. NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation.
Salah Z; Cohen S; Itzhaki E; Aqeilan RI
Cell Cycle; 2013 Dec; 12(24):3817-23. PubMed ID: 24107629
[TBL] [Abstract][Full Text] [Related]
4. S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development.
Hu Y; Zhang R; Lu S; Zhang W; Wang D; Ge Y; Jiang F; Qin X; Liu Y
Int J Biol Sci; 2023; 19(7):2034-2052. PubMed ID: 37151881
[No Abstract] [Full Text] [Related]
5. Neural precursor cell-expressed, developmentally down-regulated 4 (NEDD4) regulates hydrogen peroxide-induced cell proliferation and death through inhibition of Hippo signaling.
Jeon SA; Kim DW; Cho JY
FASEB J; 2019 Dec; 33(12):14772-14783. PubMed ID: 31690112
[TBL] [Abstract][Full Text] [Related]
6. Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth.
Lignitto L; Arcella A; Sepe M; Rinaldi L; Delle Donne R; Gallo A; Stefan E; Bachmann VA; Oliva MA; Tiziana Storlazzi C; L'Abbate A; Brunetti A; Gargiulo S; Gramanzini M; Insabato L; Garbi C; Gottesman ME; Feliciello A
Nat Commun; 2013; 4():1822. PubMed ID: 23652010
[TBL] [Abstract][Full Text] [Related]
7. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
Han Y; Tang Z; Zhao Y; Li Q; Wang E
Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
[TBL] [Abstract][Full Text] [Related]
8. microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors.
Aguennouz M; Polito F; Visalli M; Vita G; Raffa G; Oteri R; Ghazi B; Scalia G; Angileri FF; Barresi V; Caffo M; Cardali S; Conti A; Macaione V; Bartolotta M; Giorgio RD; Germanò A
Cancer Treat Res Commun; 2020; 24():100203. PubMed ID: 32777750
[TBL] [Abstract][Full Text] [Related]
9. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected].
Ho KC; Zhou Z; She YM; Chun A; Cyr TD; Yang X
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4870-5. PubMed ID: 21383157
[TBL] [Abstract][Full Text] [Related]
10. The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitin-dependent degradation.
Wang C; An J; Zhang P; Xu C; Gao K; Wu D; Wang D; Yu H; Liu JO; Yu L
Biochem J; 2012 Jun; 444(2):279-89. PubMed ID: 22385262
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
[TBL] [Abstract][Full Text] [Related]
12. [Under-expression of LATS1 promotes the differentiation, proliferation and migration of mesenchymal stem cells by inhibition the Hippo signaling pathway in vitro].
Li L; Dong L; Hui J; Gao F; Wang Q; Yang L; Zhang J; Yan J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Aug; 29(8):731-737. PubMed ID: 28795673
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.
Salah Z; Melino G; Aqeilan RI
Cancer Res; 2011 Mar; 71(5):2010-20. PubMed ID: 21212414
[TBL] [Abstract][Full Text] [Related]
14. FRMD6 inhibits human glioblastoma growth and progression by negatively regulating activity of receptor tyrosine kinases.
Xu Y; Wang K; Yu Q
Oncotarget; 2016 Oct; 7(43):70080-70091. PubMed ID: 27661120
[TBL] [Abstract][Full Text] [Related]
15. NEDD4 promotes cell growth and motility in hepatocellular carcinoma.
Zheng H; Ke X; Li D; Wang Q; Wang J; Liu X; Deng M; Deng X; Xue Y; Zhu Y; Wang Q
Cell Cycle; 2018; 17(6):728-738. PubMed ID: 29480061
[TBL] [Abstract][Full Text] [Related]
16. The SGK3-triggered ubiquitin-proteasome degradation of podocalyxin (PC) and ezrin in podocytes was associated with the stability of the PC/ezrin complex.
Yuan YP; Zhao H; Peng LQ; Li ZF; Liu S; Yuan CY; Mwamunyi MJ; Pearce D; Yao LJ
Cell Death Dis; 2018 Nov; 9(11):1114. PubMed ID: 30385740
[TBL] [Abstract][Full Text] [Related]
17. The transmembrane protein TMEPAI induces myeloma cell apoptosis by promoting degradation of the c-Maf transcription factor.
Du Y; Liu Y; Xu Y; Juan J; Zhang Z; Xu Z; Cao B; Wang Q; Zeng Y; Mao X
J Biol Chem; 2018 Apr; 293(16):5847-5859. PubMed ID: 29467225
[TBL] [Abstract][Full Text] [Related]
18. Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines.
Liu Y; Lu J; Zhang Z; Zhu L; Dong S; Guo G; Li R; Nan Y; Yu K; Zhong Y; Huang Q
Cell Death Dis; 2017 Aug; 8(8):e3022. PubMed ID: 29048430
[TBL] [Abstract][Full Text] [Related]
19. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein.
Zou J; Zhou L; Le Y; Fang Z; Zhong M; Nie F; Wei X; Zhang X; Chen Z; Cai L; Wang H; Xiong J; Fang Z; Xiang X
Cell Commun Signal; 2023 Feb; 21(1):38. PubMed ID: 36803368
[TBL] [Abstract][Full Text] [Related]
20. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions.
Mei L; Yuan L; Shi W; Fan S; Tang C; Fan X; Yang W; Qian Y; Hussain M; Wu X
Cancer Lett; 2017 Feb; 386():1-11. PubMed ID: 27847303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
